PRME - Prime Medicine, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$17.25
DETAILS
HIGH:
$23.00
LOW:
$12.00
MEDIAN:
$17.00
CONSENSUS:
$17.25
UPSIDE:
480.81%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 4.6 | 3.0 | 0 | 0 | 0 | 5.2 | 0 |
| Cost of Revenue | 7.3 | 0 | 0 | 0 | 0 | 3.0 | 2.8 |
| Gross Profit | (2.7) | 3.0 | 0 | 0 | 0 | 2.2 | (2.8) |
| Operating Expenses | |||||||
| R&D Expenses | 160.6 | 155.3 | 147.9 | 86.7 | 70.5 | 3.0 | 0.9 |
| SG&A Expenses | 52.3 | 50.2 | 43.4 | 29.8 | 13.9 | 3.2 | 1.3 |
| Other Expenses | (7.3) | 0 | 13.5 | 0 | 0 | (3.0) | 0 |
| Operating Expenses | 205.7 | 205.4 | 204.8 | 116.5 | 84.5 | 3.2 | 2.2 |
| Operating Income | |||||||
| Operating Income | (208.3) | (202.5) | (204.8) | (116.5) | (84.5) | (0.9) | (2.2) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 4.1 | 3.5 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | (195.8) | (196.3) | (186.6) | (114.3) | (83.9) | (0.9) | (2.2) |
| EBIT | (201.1) | (202.5) | (191.3) | (116.5) | (84.5) | (0.9) | (2.5) |
| Income Before Tax | (201.1) | (195.9) | (198.4) | (122.8) | (165.9) | (1.5) | (2.5) |
| Income Tax Expense | 0 | 0 | (0.3) | (0.9) | (0.5) | 1.9 | 0.0 |
| Net Income | (201.1) | (195.9) | (198.1) | (121.8) | (165.4) | (3.4) | (2.5) |
| Per Share Data | |||||||
| EPS (Basic) | -1.35 | -1.65 | -2.18 | -1.46 | -1.92 | -0.05 | -0.03 |
| EPS (Diluted) | -1.35 | -1.65 | -2.18 | -1.46 | -1.92 | -0.05 | -0.03 |
| Shares Outstanding | 148.8 | 118.6 | 91.0 | 97.2 | 95.7 | 95.7 | 95.7 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 63.0 | 182.5 | 41.6 | 187.6 | 185.4 | 37.0 | 8.6 |
| Short-Term Investments | 114.6 | 8.0 | 80.1 | 106.3 | 84.2 | 16.4 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.6 | 14.7 | 2.3 | 0.2 | 0 | 0 | 0.1 |
| Total Current Assets | 181.3 | 211.9 | 143.0 | 296.6 | 270.6 | 53.4 | 8.7 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 146.7 | 71.6 | 36.6 | 48.6 | 15.7 | 0.6 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 14.7 | 14.1 | 14.3 | 15.1 | 15.6 | 0.8 | 0 |
| Total Non-Current Assets | 161.4 | 85.6 | 50.9 | 63.7 | 31.3 | 1.4 | 0 |
| Total Assets | 342.7 | 297.5 | 193.9 | 360.3 | 301.9 | 54.8 | 8.7 |
| Current Liabilities | |||||||
| Account Payables | 8.9 | 11.4 | 19.5 | 4.3 | 1.4 | 0.2 | 0 |
| Short-Term Debt | 8.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 7.8 | 7.1 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 12.6 | 6.9 | 10.9 | 7.0 | 14.7 | 19.1 | 7.3 |
| Total Current Liabilities | 37.4 | 38.0 | 56.4 | 26.7 | 58.0 | 19.4 | 7.3 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 108.3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0.3 | 1.2 | 1.9 | 0 |
| Other Non-Current Liabilities | 76.1 | 6 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 184.4 | 106.4 | 4.4 | 17.3 | 4.3 | 1.9 | 0 |
| Total Liabilities | 221.9 | 144.4 | 60.8 | 44.0 | 62.3 | 21.3 | 7.3 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0.0 |
| Retained Earnings | (888.4) | (687.2) | (491.3) | (293.2) | (171.4) | (6.0) | (2.6) |
| Accumulated Other Comprehensive Income | 0.1 | 0.0 | (0.0) | (0.4) | (0.0) | 0 | 0 |
| Total Stockholders' Equity | 120.9 | 153.1 | 133.1 | 316.3 | 239.6 | 33.5 | 1.4 |
| Total Liabilities & Equity | 342.7 | 297.5 | 193.9 | 360.3 | 301.9 | 54.8 | 8.7 |
| Debt Metrics | |||||||
| Total Debt | 116.4 | 40.8 | 13.6 | 28.7 | 10.4 | 0 | 0 |
| Net Debt | 53.4 | (141.7) | (27.9) | (158.9) | (175.0) | (37.0) | (8.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (201.1) | (195.9) | (198.1) | (121.8) | (165.4) | (3.4) | (2.5) |
| Depreciation & Amortization | 5.4 | 6.1 | 4.7 | 2.2 | 0.6 | 0.0 | 0 |
| Stock-Based Compensation | 29.3 | 26.1 | 13.9 | 6.5 | 1.7 | 0.4 | 0 |
| Change in Working Capital | (5.3) | 31.1 | 2.6 | (35.4) | 31.2 | 0.2 | 0.5 |
| Other Non-Cash Items | 9.3 | 9.7 | 11.8 | 17.7 | 98.4 | (4.6) | 0.7 |
| Operating Cash Flow | (162.6) | (122.9) | (165.4) | (131.8) | (34.1) | (5.5) | (1.3) |
| Investing Activities | |||||||
| Capital Expenditure | (4.5) | (7.3) | (8.7) | (16.1) | (4.2) | (0.6) | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (205.4) | (129.4) | (105.0) | (123.3) | (82.0) | 0 | 0 |
| Sales/Maturities of Investments | 101.2 | 204.2 | 132.6 | 93 | 13 | 0 | 0 |
| Other Investing Activities | 0 | 1 | (0.2) | (0.7) | (0.5) | (0.4) | 0 |
| Investing Cash Flow | (108.8) | 68.5 | 18.7 | (47.1) | (73.6) | (1.1) | 0 |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 12 | 25.7 | 0 | (3.8) | (1.1) | (0.0) | 0 |
| Financing Cash Flow | 151.5 | 195.9 | 0.7 | 181.5 | 269.3 | 34.9 | 10.0 |
| Cash Position | |||||||
| Net Change in Cash | (119.8) | 141.5 | (146.0) | 2.6 | 161.6 | 28.3 | 0 |
| Cash at Beginning | 196.5 | 55.1 | 201.1 | 198.5 | 37.0 | 8.6 | 0 |
| Cash at End | 76.7 | 196.5 | 55.1 | 201.1 | 198.5 | 37.0 | 0 |
| Free Cash Flow | (167.1) | (130.2) | (174.1) | (147.9) | (38.2) | (6.2) | (1.3) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 4.6 | 3.0 | 0 | 0 | 0 | 5.2 | 0 |
| Gross Profit | (2.7) | 3.0 | 0 | 0 | 0 | 2.2 | (2.8) |
| Operating Income | (208.3) | (202.5) | (204.8) | (116.5) | (84.5) | (0.9) | (2.2) |
| Net Income | (201.1) | (195.9) | (198.1) | (121.8) | (165.4) | (3.4) | (2.5) |
| EPS (Diluted) | -1.35 | -1.65 | -2.18 | -1.46 | -1.92 | -0.05 | -0.03 |
| Balance Sheet | |||||||
| Cash & Equivalents | 63.0 | 182.5 | 41.6 | 187.6 | 185.4 | 37.0 | 8.6 |
| Total Assets | 342.7 | 297.5 | 193.9 | 360.3 | 301.9 | 54.8 | 8.7 |
| Total Debt | 116.4 | 40.8 | 13.6 | 28.7 | 10.4 | 0 | 0 |
| Stockholders' Equity | 120.9 | 153.1 | 133.1 | 316.3 | 239.6 | 33.5 | 1.4 |
| Cash Flow | |||||||
| Operating Cash Flow | (162.6) | (122.9) | (165.4) | (131.8) | (34.1) | (5.5) | (1.3) |
| Capital Expenditure | (4.5) | (7.3) | (8.7) | (16.1) | (4.2) | (0.6) | 0 |
| Free Cash Flow | (167.1) | (130.2) | (174.1) | (147.9) | (38.2) | (6.2) | (1.3) |